Effect of vaginal antiseptic prior to Caesarean Section on the rate of Post-Caesarean complications: A blinded randomised controlled trial

Not Applicable

• Conditions: postpartum sepsis; Reproductive Health and Childbirth - Childbirth and postnatal care; Infection - Other infectious diseases

• Registration Number: ACTRN12620000971932
• Lead Sponsor: Goulburn valley health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-09-28
• Last Update Posted: 19 October 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 375

Inclusion Criteria

Any patients undergoing for either emergency or elective CS that provided voluntary informed consent will be included in the study.

Exclusion Criteria

•Patients having signs of chorio, intrapartum pyrexia and other signs of infection will be excluded from the study.
•Patients who develop intrapartum pyrexia as a result of syntocinon drip, prolonged labour or obstructed labour and provided voluntary informed consent will be included in the study initially. Their placental swabs will be taken for microscopic examination, culture and sensitivity (m/cs). They will be excluded from the study only if their swab results are positive for m/cs.

Study & Design

• Study Type: Interventional
• Study Design: Not specified